A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Clinical trial NCT02389244 · COMPLETED

Trial details

NCT number: NCT02389244
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ewing Sarcomas Chondrosarcomas Osteosarcomas Chondroma CIC-Rearranged Sarcoma

Start date: 2014-09-01
Primary completion: 2024-10-25
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.